SCHEMBL10501656

SCHEMBL10501656

N[N]CCN1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.43
GLA P06280 1/20 0.42
RXFP1 Q9HBX9 1/20 0.39
HPGD P15428 1/20 0.38
DUSP3 P51452 1/20 0.38
USP2 O75604 1/20 0.38
GAA P10253 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
POLB P06746 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5496326 0.80 KDM4E (0.50) KEAP1SMN1; SMN2KDM4EALDH1A1CYP1A2
SCHEMBL235080 0.79 KDM4E (0.65) KEAP1SMN1; SMN2KDM4EALDH1A1GLA
SCHEMBL10501575 0.77
SCHEMBL6077409 0.76 KDM4E (0.46) KEAP1SMN1; SMN2KDM4EALDH1A1CYP1A2
SCHEMBL674062 0.76 ALDH1A1 (0.52) KEAP1SMN1; SMN2KDM4EALDH1A1CYP1A2
SCHEMBL6044315 0.76 GLA (0.47) KEAP1SMN1; SMN2KDM4EALDH1A1CYP1A2
SCHEMBL18434868 0.76 KDM4E (0.46) KEAP1SMN1; SMN2KDM4EALDH1A1CYP1A2
SCHEMBL20329460 0.76 SMN1; SMN2 (0.46) KEAP1SMN1; SMN2KDM4EALDH1A1CYP1A2
SCHEMBL11856358 0.76 KDM4E (0.70) KEAP1SMN1; SMN2KDM4EALDH1A1GLA
SCHEMBL10913328 0.76 KDM4E (0.70) KEAP1SMN1; SMN2KDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0171217-B1 FUSED-RING HETEROCYCLIC COMPOUNDS A PROCESS FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE SANKYO COMPANY LIMITED (JP) 1989-05-03 EP disclosed
US-4716162-A BRAIN FUNCTION SANKYO COMPANY, LIMITED (JP) 1987-12-29 US disclosed
EP-0171217-A2 Fused-ring heterocyclic compounds a process for their production and their pharmaceutical use SANKYO COMPANY LIMITED (JP) 1986-02-12 EP disclosed